HAEMATOLOGICA

Rivista

Codice:

E073847

ISSN:

0390-6078

Dati Generali

Pubblicazioni (232)

5-azacitidine five days/monthly schedule in symptomatic low-risk (IPSS: 0-1) myelodisplastic (MDS) patients. clinical and biological effects.

Contributo in Atti di convegno

A Cooperative Study on the Therapy of Acute Lymphoblastic Leukemia. Results of the Italian Association against Leukemia

Articolo

A NEW PROMISING APPROACH TO PERFORM HLA TYPING IN A QUICKLY, SIMPLE AND ACCURATE WAY: THE PYROSEQUENCING

Abstract

A SIMPLE CLINICAL PROGNOSTIC SCORING SYSTEM FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKAEMIA PATIENTS WITH NORMAL KARYOTYPE: A RETROSPECTIVE ANALYSIS ON 530 CASES.

Abstract

A case of Richter's syndrome due to the spontaneous proliferation of two immunologically unrelated B cell malignancies

Articolo

A prospective comparison of alpha-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients

Articolo

A prospective study of alphaInterferon and autologous bone marrow transplantation in chronic myeloid leukemia

Articolo

A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients.

Abstract

AZACITIDINE LOW-DOSE SCHEDULE IN SYMPTOMATIC LOW-RISK (IPSS: 0-1) MYELODISPLASTIC PATIENTS. CLINICAL AND BIOLOGICAL EFFECTS.

Contributo in Atti di convegno

Achievement of complete remission with Ponatinib therapy for Philadelphia positive acute lymphoblastic leukemia relapsed after allogeneic stem cell transplantation: a case report

Abstract

Acute myeloid leukemia in the elderly: results obtained with conventional chemotherapy

Abstract

Advances in prognosis of chronic myeloid leukemia.

Articolo

All-trans retinoic acid (ATRA) potentiates the in vitro inhibitory effects of IFN-alfa in parental (32D) and p210-bcr/abl transfected (LG7) murine myeloid cell lines.

Articolo

All-trans retinoic acid in hematological malignancies. An update

Articolo

Allogeneic Stem Cell Transplantation (SCT) for myelodysplastic synromes (MDS) and secondary acute myeloid leukemia. Retrospective study of 32 patients from a single institution.

Abstract

Allogeneic stem cell transplantation after a RIC regimen prolongs the survival in patients with Hodgkin lymphoma relapsed after high-dose chemotherapy: a retrospective study based on donor availability.

Abstract

Alpha-Interferon as maintenance drug after initial Fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma".

Articolo

Alpha-L-fucosidasi: possibile marker istochimico per la LLA?

Contributo in Atti di convegno

Alpha-interferon as an alternative to allogeneic bone marrow transplantation in the treatment of positive adult acute lymphoblastic leukemia.

Abstract

Analisi dell’impatto della profilassi antifungina in 42 bambini affetti da LLA in terapia

Articolo

Analysis of the iron status of professional cyclistd during a 3-week road race

Articolo

Antiangiogenic activity and clinical efficacy of thalidomide in myelodiysplastic syndromes: report of two cases.

Abstract

Antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia and myelodisplastic syndromes. Analysis of microvessels density and angiogenesis surrogate markers.

Abstract

Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts.

Articolo

Association of 3q26 syndrome with different RPN1/EVI1 fusion transcripts in acute myeloblastic leukemia patients.

Abstract

Assoication of 3q21 syndrome with different RPN1/EVI1 fusion transcript in AML patients.

Abstract

B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia

Articolo

BRENTUXIMAB VEDOTIN FOR HODGKIN LYMPHOMA WHO HAD FAILED ALLOGENEIC STEM CELL TRANSPLANTATION: A MULTICENTER RETROSPECTIVE STUDY

Contributo in Atti di convegno

Banca di cordone dedicato per malattie genetiche: l’esperienza del centro di Brescia 1996-2008

Articolo

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications

Articolo

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.

Articolo

Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target

Articolo

CAR T expansion and systemic inflammation: diverging impacts on large B-cell lymphoma therapy in the multicenter CART SIE study

Articolo

CIRCULATING ENDOTHELIAL CELLS (CEC) ARE A RELIABLE AND DYNAMIC BIOMARKER OF ACUTE GVHD (AGVHD) IN PATIENTS UNDERGOING ALLOGENEIC STEM CELLS TRANSPLANTATION

Abstract

CO43 | Fourier-transform infrared spectroscopy of plasma as a liquid biopsy for monitoring acute myeloid leukemia and extramedullary relapse following allo-HSCT

Abstract

COMBINED EFFECTS OF MESENCHYMAL STROMAL CELLS (MSC) AND STIMULATORY CYTOKINES ON THE ex vivo GROWTH OF UMBILICAL CORD BLOOD HEMATOPOIETIC PROGENITOR CELLS (UCB-HPC)

Abstract

CYTOGENETIC RESPONSE, MOLECULAR RESPONSE AND OUTCOME OF ELDERLY PH+ CML PATIENTS WITH STABLE COMPLETE CYTOGENETIC RESPONSE AFTER 4-YEARS OF INTERMITTENT TREATMENT WITH IMATINIB (INTERIM)

Abstract

CYTOPLASMIC NUCLEOPHOSMIN IS NOT DETECTED IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM.

Articolo

Characterization of a new t(5;17)(q35;q21) variant acute promyelocytic leukemia

Abstract

Chronic GVHD and sequential study of cytokine patterns and lymphocyte subsets in patients underwent allogeneic stem cell transplantation with reduced intensity conditioning.

Abstract

Chronic myeloid leukemia patients with complete karyotypic response to STI-571 (GLIVEC) therapy show rapid reduction of bcr-abl trancripts.

Abstract

Chronic myeloid leukemia: Room for improvement?

Articolo

Citometria a flusso della diidrofolico reduttasi nei blasti di leucemia acuta all'esordio e nelle recidive

Contributo in Atti di convegno

Clinical and biological effects of 5-azacytidine five days/monthly in symptomatic low-risk (IPSS: 0-1) myelodisplastic patients.

Abstract

Clinical effects of 5-azacitidine five days/monthly schedale in three symptomatic low-risk (IPSS: 0 – 1) myelodisplastic patients.

Abstract

Clinical effects of 5-azacitidine five days/monthly schedale in three symptomatic low-risk (IPSS: 0 – 1) myelodisplastic patients.

Abstract

Collection of Ph-negative progenitor cells from Ph+ CML patients in complete cytogenetic remission after long-term interferon-alfa therapy

Articolo

Comparsa di metastasi al muscolo ileo.psoas in paziente a tre anni dalla diagnosi di osteosarcoma osteoblastico

Articolo

Complete cytogenetic remission in acute myeloid leukemia with granulocyte colony stimulating factor without chemotherapy. A case report.

Abstract

Complete haematological response after low dose rituximab in a patient with refractory warm-type autoimmune haemolytic anemia.

Abstract

Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22;q23) positive AML patient and review of literature.

Articolo

Computed tomography magnetic resonance and Gallium 67 scintigrafy for the imaging of residual lymphoma

Articolo

Correlation between the response to induction treatment, including or not fludarabine and the MDR phenotype in newly diagnosed acute myeloid leukemia patients. Results of a case-control study.

Abstract

Cyclosporin-A (CS-A) for refractory coombs-negative autoimmune hemolitic anemia.

Abstract

Cytochemical study of tetrahydrofolate dehydrogenase in myelodisplastic syndromes

Articolo

Cytokine gene expression and T-cell proliferative responses in lymph node mononuclear cells from children with early stage human immunodeficiency virus infection.

Articolo

D1CLEARANCE OF HEPATITIS B VIRUS INFECTION IN A PATIENT RECEIVING ALLOGENEIC BONE MARROW TRANSPLANTATION FROM AN HBV NAIVE DONOR.

Abstract

DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION

Abstract

DNA-topoisomerase I and II: biologic features and their role in drug resistance

Articolo

De novo acute B-cell lymphoblastic leucemia with t(14;18) and bcr/abl rearrangement: a case report.

Abstract

Development of autoimmune thyroid diseases during long-term treatment of hematological malignancies with alpha-interferons

Articolo

EARLY EXTRACORPOREAL PHOTOAPHERESIS FOR THE TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE (AGVHD).

Abstract

EXPRESSION OF TOLL-LIKE RECEPTORS ON PERIPHERAL BLOOD CELLS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: ONGOING RESULTS OF A PROSPECTIVE STUDY.

Abstract

EXTRACORPOREAL PHOTOPHERESIS FOR THE TREATEMENT OF ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: A RETROSPECTIVE MULTICENTRIC ANALYSIS ON 94 PATIENTS.

Abstract

Effect of Fludarabine and arabinosylcytosine on multidrug resistant cells

Articolo

Efficacy and feasibility of Gemtuzumab Ozogamicin plus cytarabine in the treatment of poor risk acute myeloid leukemia.

Abstract

Efficacy and toxicity of FLAI vs ICE for induction treatment of newly diagnosed AML paztients, younger than 60 years.

Abstract

Efficacy and toxicity of FLAI-G-CSF and mylotarg for induction/consolidation of poor-risk AML patients.

Abstract

Efficacy and toxicity of fludarabine, AraC, and idarubicine versus idarubicine, AraC and etoposide for induction treatment of newly diagnosed acute myeloid leukemia in patients younger than 60 years

Abstract

Efficacy of imatinib mesylate (STI 571) in conjunction with -interpheron: long term quantitative molecular remission in relapsed positive acute lymphoblastic leukemia.

Abstract

Efficacy of thalidomide in myelofibrosis with myeloid metaplasia.

Abstract

Eterogeneità fenotipica in una famiglia con SCID da deficit di JAK3: analisi molecolare e biochimica”

Articolo

European consensus on grading bone marrow fibrosis and assessment of cellularity.

Articolo

Expansion of large lymphocyte subsets in Wiskott-Aldrich syndrome.

Articolo

Expression of CD34 by megakaryocytes in myelodysplastic syndromes

Articolo

FIP1L1-PDGFRA fusion gene as a therapeutic target of imatinib in hypereosinophilic syndrome: clinical and biological features.

Abstract

FLAIE (Fludarabine, cytarabine, idarubicin and etoposide) induction chemotherapy for adult acute myeloid leukemia. Results of a pilot study

Abstract

FUNCTIONAL DEFICIT OF IL-10 IN NEUTROPHILS AND MONOCYTES AS A ARESULT OF ALTERED INFLAMMATORY RESPONSE IN PATIENTS WITH HYPER IGE SYNDROME

Abstract

Fenotipo clinico, valutazione immunologia e analisi molecolare in pazienti affetti da trombocitemia isolata X-recessiva (XLT)

Articolo

Fludarabine and cytosine-arabinoside for poor-risk acute myeloid leukemia

Articolo

Fludarabine, AraC and Idarubicin versus Idarubicin, AraC and Etoposide for induction treatment of younger newly diagnosed AML patients: a multicenter phase III trial.

Contributo in Atti di convegno

Fludarabine, Arabinosil cytosine, Idaubicine (FLAI): a combination of a non MDR-related drugs for treatment of patients with newly diagnosed acute myeloid leukemia.

Abstract

Fludarabine, Cytarabine, Idarubicine and Etoposide (FLAIE) schedule is safe and active for young patients with newly diagnosed AML: results of a multicentric phase III italian sttudy.

Abstract

Fludarabine, arabynosil cytosine and idarubicine (FLAI), a combination of non MDR-related drugs for treatment of patients with newly diagnosed acute myeloid leukemia

Abstract

Four Drugs combination (Fludarabine, Cytarabine, Idarubicin, Etoposide) as induction therapy for newly diagnosed acute myeloid leukemia patients younger than 65 yrs: response and follow up of 127 patients.

Abstract

Four-drugs induction intensified regimens (idarubicin, cytarabine and etoposide plus fludarabine or mylotarg – FLAIE and MyAIE) for acute myeloid leukemia. Results of a pilot study.

Contributo in Atti di convegno

Fungal infections in acute myeloid leukemia patients treated with induction regimens including fludarabine: a retrospective analysis of 224 cases

Abstract

Fungal infections in acute myeloid leukemia patients treated with induction regimens including fludarabine: a retrospective analysis of 224 cases.

Abstract

GENOMIC ANALISYS OF NOTCH MUTATIONS IN CASE OF ALAGILLE SYNDROME WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Abstract

Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency

Articolo

Human immunodeficiency virus testing in acute leukemia patients transufsed between 1978 and 1985: a retrospective study in 91 cases.

Articolo

Hypereosinophilic sindrome treated with imatinib therapy: clinical and biological analysis.

Abstract

IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF)

Abstract

INTRA BONE MARROW TRANSPLANTATION OF UMBILICAL CORD BLOOD HEMATOPOIETIC STEM CELL: A REPORT OF TWO CASES.

Abstract

Identification of two novel mutations in the 5'-untranslated region of H-ferritin using denaturing high performance liquid chromatography scanning

Articolo

Imatinib in adult and elderly Ph+ ALL patients: preliminary results of the GIMEMA prospective study LAL0201.

Abstract

Imatinib mesylate as experimental therapy in systemic mastocytosis with D816V c-kit mutation but without FIP1L1-PDGFR-alpha fusion transcript.

Abstract

Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome.

Articolo

Imatinib mesylate can induce molecular complete remission in idiopathic hypereosinophilic sindrome. A phase II multicentric Italian clinical trial.

Abstract

Imatinib mesylate in the treatment of newly diagnosed or refractory /resistant c-kit positive AML. Results of an italian multicentric phase II study.

Abstract

Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-kit positive acute myeloid leukemia. Results of an italian multicentric phase II study.

Abstract

Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant kit positive acute myeloid leukemia. Results of an italian multicentric phase II study.

Articolo

Imatinib mesylate therapy is not effective in systemic mastocytosis with D816V c-kit mutation.

Abstract

Immunoassay for human serum hemojuvelin

Articolo

Immunohistochemistry of HFE in the duodenum of C282Y homozygotes with antisera for recombinant HFE protein

Articolo

In vitro activity of tyrosine kinase, farnesyl transferase and AKT kinase inhibitors on c-kit positive/negative and ;DR-pgp positive/negative leukaemia tumor cell lines.

Abstract

In vitro activity of tyrosine kinase, farnesyl transferase and akt kinase inhibitors on c-kit positive/negative and mdr-pgp positive/negative leukaemia tumor cell lines.

Abstract

Incidence of bacterial and fungal infections in acute myeloid leukemia patients treated with induction regimens including fludarabine: a retrospective analysis of 224 cases

Abstract

Induction intensified regimens includine fludarabine or gemtuzumab ozogamicin for AML patients: comparison by response and follow up.

Abstract

Influence of additional chromosome abnormalities to PH on response to imatinib mesylate therapy in early chronic phase in chronic myeloid leukemia

Abstract

Intensive polychemotherapy experience in chronic myeloid leukemia

Articolo

Intermittent Imatinib (INTERIM) Treatment in Ph+-CML elderly patients in stable Complete Cytogenetic Response.

Abstract

Istochimica quantitativa della diidrofolico reduttasi nei blasti delle leucemie mieloidi acute

Contributo in Atti di convegno

Italian cooperative study on idiopathic hypereosinophilic syndrome (HES): FIP1-L1/PDGFRA rearrangement can effectively be treated with imatinib.

Abstract

LONG TERM OUTCOME OF INTERMITTENT IMATINIB TREATMENT POLICY FOR MANAGINGCHRONIC MYELOID LEUKEMIA IN THE ELDERLY

Abstract

Laparoscopic splenectomy in the management of hematological diseases

Articolo

Late taste disorders in bone marrow transplantation: clinical evaluation with taste solutions in autologous and allogeneic bone marrow recipients.

Articolo

Le alterazioni gustative nei trapianti di midollo osseo allogenico per emopatie maligne. Ricerche preliminari

Articolo

Liposomal daunorubicin (DAUNOXOME) for treatment of relapsed meningeal acute myeloid leukemia.

Abstract

Liposome encapsulated daunorubicin (Daunoxme) for acute leukemia.

Articolo

Long-term culture of chronic myeloid leukemia (CML) bone marrow cells

Articolo

Long-term follow-up of essential thrombocythemia in young adults: Treatment strategies, major thrombotic complications and pregnancy outcomes. A study of 76 patients

Articolo

Long-term molecular complete remission with pulsed ATRA as single agent in PML-RARalpha-positive acute promyelocytic leukemia. 10th Congress of the European Hematology Association, Stoccolma, Svezia, 2 – 5 giugno 2005. Haematologica 90;2: 0035.

Abstract

Long-term molecular complete remission with pulsed ATRA as single agent in PML-RAR-positive acute promyelocytic leukemia

Abstract

Long-term results of splenectomy in adult chronic idiopathic thrombocytopenic purpura

Articolo

Low dose Gemtuzumab Ozogamicin for relapsed acute myeloid leukemia in elderly.

Articolo

Low dose gemtuzumab ozogamicin plus fludarabine, cytarabine, idarubicin (GO-FLAI) as induction therapy in CD33-positive acute myeloid leukemia (AML) patients younger than 65 years. Interim results from a phase III multicenter prospective clinical trial (MY-FLAI07-NCT.00909168).

Abstract

Low-Dose Cytosine Arabinoside (ARA-C) Therapy in the Myelodysplastic Syndromes and Acute Myelogenous Leukemia.

Articolo

Low-dose interferon-alpha in Ph+ chronic myeloid leukemia: clinical, cytogenetic and cell culture study.

Articolo

M-BCR breakpoint location does not predict survival in Philadelphia chromosome-positive chronic myeloid leukemia

Articolo

MALNUTRITION AND GVHD IN ALLOGENIC BONE MARROW TRANSPLANTATION: A PROSPECTIVE STUDY

Abstract

MMA monoclonal antibody is a superior anti-CD15 reagent for the diagnosis of classical Hodgkin's lymphoma?

Articolo

MONITORING OF COMPLETE CYTOGENETIC RESPONSE (CCGR) BY INTERPHASE FLUORESCENCE IN SITU HYBRIDIZATION (I-FISH) ON PERIPHERAL BLOOD IN ELDERLY PH+ CML PATIENTS WITH STABLE CCGR TREATED WITH INTERMITTENT IMATINIB (IM)EUDRACT NUMBER 2007-005102-42, CLINICALTRIALS.GOV NCT 00858806.

Abstract

MULTI-GENOTYPE OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) TO STUDY GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECTS IN ALLOGENEIC STEM CELL TRANSPLANTATION.

Abstract

MULTI-GENOTYPING OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) TO EVALUATE THEIR ROLE IN DETERMINING GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECTS IN ALLOGENEIC STEM CELL TRANSPLANTATION

Abstract

Mental depression, acute infection and coma in a patient treated with interferon-alpha

Articolo

Micosi cerebrali: aggiornamento clinico di due pazienti affeti da LLA

Articolo

Minimal residual disease monitoring by real time PCR during treatment with STI571 for bcr-abl positive acute lymphoblastic leukemia.

Abstract

Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis

Articolo

Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely.

Articolo

Molecular therapy of AML: a new and rapid method to characterize novel genetic variants in FLT3 gene

Abstract

Monoclonal expansion of large granular lymphocytes with a CD4+ CD8dim+/- phenotype associated with hairy cell leukemia

Articolo

Multicenter phase III trial on fludarabine, ara-C and idarubicine (FLAI) versus idarubicine, ara-C and etoposide (ICE) for induction treatment of younger newly diagnosed AML patients

Abstract

Multisystem autoimmune disease caused by increased STAT3 phosphorylation and dysregulated gene expression

Articolo

New TFR2 mutations in young Italian patients with hemochromatosis.

Articolo

No preferential sensitivity of t(8;21) acute myeloid leukemia cells to cytosine arabinoside in vitro

Abstract

OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY

Abstract

On the potential involvement of CD11d in co-stimulating the production of interferon-γ by natural killer cells upon interaction with neutrophils via intercellular adhesion molecule-3.

Articolo

Other targets for Imatinib therapy

Abstract

Overcoming PGP-related multidrug resistance. The cyclosporine derivative SDZ PSC 833 can abolish the resistance to methoxy-morpholynil-doxorubicin

Articolo

Overexpression of mdr-related p170 glycoprotein in chronic myeloid leukemia

Articolo

P022 | Fourier-transform infrared spectroscopy analysis of plasma-derived extracellular vesicles as a tool to detect TKI-related toxicity in chronic myeloid leukemia patients: a preliminary study

Abstract

P026 | Tracking residual chronic myeloid leukemia: complementary insights from CD26⁺ stem cells and extracellular BCR::ABL1

Abstract

P044 | From cells to vesicles: next-generation measurable residual disease tracking in acute myeloid leukemia with NGS and digital PCR

Abstract

P046 | Beyond the mutation: prognostic role of FLT3-ITD length and genomic context in acute myeloid leukemia

Abstract

P170-dependent multidrug resistance. Restoring full sensitivity to idarubicin with verapamil and cyclosporin a derivatives

Articolo

PARAMETERS OF PROTEIN METABOLISM AND THYROID FUNCTION AS PREDICTORS OF A SCORING SYSTEM FOR ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE

Abstract

POSSIBLE CORRELATION BETWEEN DIFFERENT TOLL-LIKE RECEPTORS, MONOCYTES, LYMPHOCYTE SUBSETS, TYPE OF INFECTIONS AND OUTCOME AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

Abstract

POST REMISSION MONITORING OF MINIMAL RESIDUAL DISEASE BY WT1 AND LEUKEMIA ASSOCIATED IMMUNOPHENOTYPE PREDICTS RELAPSE IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS

Abstract

POST REMISSION SEQUENTIAL MONITORING OF MINIMAL RESIDUAL DISEASE BY WT1 Q-PCR AND MULTIPARAMETRIC FLOW CYTOMETRY PREDICTS RELAPSE AND MAY HELP TO ADDRESS THE RISK ADAPTED THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS

Abstract

PRE-FINAL ANALYSIS OF THE PHASE II EXPLORATIVE STUDY OF INTERMITTENT IMATINIB (IM) TREATMENT (INTERIM) IN ELDERLY PH+ CML PATIENTS WITH STABLE COMPLETE CYTOGENETIC RESPONSE (CCGR) – EUDRACT NUMBER 2007-005102-42, CLINICALTRIALS.GOV NCT 00858806.

Abstract

PROGNOSTIC RELEVANCE OF WT1 MOLECULAR LEVELS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION.

Abstract

PYROSEQUENCING IS A NEW PROMISING APPROACH TO PERFORM HLA TYPING IN A QUICKLY, SIMPLE AND ACCURATE WAY.

Abstract

Pharmacology treatment of chronic asthma.

Articolo

Phase II multicentric explorative study of Intermittent Imatinib (IM) treatment (INTERIM) in elderly patients with Ph+ chronic myeloid leukemia (CML) who achieved a stable complete cytogenetic response (CCgR) with standard IM therapy.

Abstract

Phase II multicentric explorative study of Intermittent Imatinib (IM) treatment (INTERIM) in elderly patients with Ph+ chronic myeloid leukemia (CML) who achieved a stable complete cytogenetic response (CCgR) with standard IM therapy.

Abstract

Phase II pilot trial of gemtuzumab ozogamicin (mylotarg) in combination with fludarabine, cytarabine, idarubicin (FLAI) as induction therapy in CD33+ AML patients younger than 65 years.

Abstract

Phase II study of bisantrene in relapsed/refractory acute non lymphoid leukemias (ANLL)

Articolo

Pilot study of combined therapy with interferon-alfa, arabinosyl cytosine and all-trans retinoic acid in patients with chronic myeloid leukemia in the chronic phase

Articolo

Plasma cell P170 expression and response to treatment in multiple myeloma

Articolo

Polarization dictates iron handling by inflammatory and alternatively activated macrophages.

Articolo

Polyclonal T-cell expansions in a HIV(+) patient with atypical cutaneous lymphoproliferative disorder, large granular lymphocyte proliferation and SENV infection

Articolo

Post-transplant evaluation of bone marrow hematopoietic function in patients receiving high-dose Yttrium-90-Ibritumomab Tiuxetan (Zevalin) with autograft

Abstract

Primary adrenal insufficiency, circulating lupus anticoagulant and anticardiolipin antibodies in a patient with multiple abortions and recurrent thrombotic episodes.

Articolo

Proliferation and maturation effects of in-vivo granulocyte-macrophage colony stimulating factor in acute non-lymphocytic leukaemia

Articolo

Prompt resolution of nasal aspergillosis with intra-nasal instillation of liposomal amphotericin-B (ambisome) and granulocyte transfusione. A case report.

Abstract

Prospective phase II study on low dose 5-Azacitidine for treatment of symptomatic patients with low/intermediate-1 myelodisplasia.

Abstract

Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease.

Articolo

Quantification of bcr/abl expression by Real-Time PCR in patients with chronic myeloid leukemia.

Abstract

Quantification of bcr/abl mRNA expression by a rapid real-time reverse transcription-polymerase chain reaction assay in patients with chronic myeloid leukemia.

Articolo

Quantitative RT-PCR identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission is likely in inv(16)-positive acute myeloid leukemia patients.

Abstract

RESULTS OF THE IMPLEMENTATION OF THE AIEOP RECOMMENDATIONS FOR AGAMMAGLUBOLINEMIA X-RECESSION (SLA): NATUAL HISTORY AND QUALITY OF LIFE OF 139 PATIENTS WITH XLA

Abstract

Rapid detection of FLT3 mutations in acute myeloid leukemia patients by denaturing high-performance liquid chromatography.

Abstract

Rare CBFbeta-MYH11 fusion transcripts in patients with acute myeloid leukemia associated with inversion of chromosome 16.

Abstract

Real-time quantification of minimal residual disease in inv(16) positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.

Abstract

Recombinant granulocyte-colony stimulating factor as treatment for poor prognosis oligoblastic acute myeloid leukemia in elderly patients.

Articolo

Reconstitution of T-cell compartment after in utero stem cell transplantation: analysis of T-cell repertoire and thymic output.

Articolo

Regulation of the proliferative potential of cord blood long-term-colture-initiating cells (LTC-IC) by different stromal cell lines: implications for LTC-IC measurement

Articolo

Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.

Articolo

Reply to "A combination treatment approach and cord blood stem cell transplant for blastic plasmacytoid dendritic cell neoplasm" and to "A low-grade B-cell lymphoma with prolymphocytic/paraimmunoblastic proliferation and IRF4 rearrangement" dendritic cell leukemia.

Articolo

Response to sequential treatment with lymphoblastoid interferon-alpha in patients with Ph+ chronic myeloid leukemia unresponsive to recombinant interferon- alpha (rIFN alpha 2a) and neutralizing rIFN alpha 2a antibobies negative.

Articolo

Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome

Articolo

Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and 2-chlorodeoxyadenosine

Articolo

Rituximab for the treatment of type II mixed cryoglobulinemia

Articolo

Role of the phase of the disease at transplant in acute myeloid leukemia patients: experience of Bologna.

Abstract

SIRPB1: BIOMARKER OF RESPONSE TO 5-AZACITIDINE TREATMENT IN MDS AND AML PATIENTS

Abstract

SIRPB1: BIOMARKER OF RESPONSE TO 5-AZACITIDINE TREATMENT IN MDS AND AML PATIENTS

Abstract

SUSTAINED LONG TERM COMPLETE HAEMATOLOGICAL RESPONSE WITH LOW DOSE RITUXIMAB IN A PATIENT WITH REFRACTORY WARM-TYPE AUTOIMMUNE HAEMOLYTIC ANAEMIA.

Abstract

Safety and efficacy of the four drug induction regimen My-FLAIG-3 (Mylotarg, Fludarabine, Cytarabine and Idarubicin) for elderly acute myeloid leukemia patients. Results of a phase II pilot study.

Abstract

Second chronic phase before transplantation is crucial for improving survival of blastic phase chronic myeloid leukemia.

Abstract

Septicemia in Hematologic Malignancies: Statistical Analysis of Prognostic Factors

Articolo

Sequential study of cytokine and lymphocyte patterns in patients with chronic graft versus host disease after reduced intensity conditioning allogeneic stem cell transplantation.

Abstract

Sequential thalidomide and erythropoietin in idiopathic myelofibrosis: a succesful combination.

Abstract

Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha

Articolo

Serum lactate dehydrogenase is an important risk determinant in acute lymphocytic leukaemia.

Articolo

Single Center experience of detection of minimal residual disease in patients with AML1/ETO associated acute myeloid leukemia by RT-PCR.

Abstract

Soft tissue and skeletal involvement in FIP1L1-PDGFR-A positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission

Articolo

Spinal cordal compression by extramedullary hematopoietic tissue in a thalassemic patient: prompt effect of radiotherapy

Articolo

Splenectomy as a curative treatment for immune thrombocytopenia: A retrospective analysis of 233 patients with a minimum follow up of 10 years

Articolo

Study of plasmatic activities inhibiting cell transformation in vitro

Articolo

Superiority of RIC allogeneic transplantation over conventional treatment for HL patients relapsing after autologous transplantation: a GITMO retrospective study based on time of HLA-typing and donor availability.

Abstract

Sustained molecular remission in advanced acute promyelocytic leukemia with complete pulsed retinoic acid and arsenic trioxide. Clinical evidence af synergistic effect and real-time quantification of minimal residual disease

Articolo

Systematic evaluation of hypereosinophilic sindrome-related organ damage accordino to FIP1L1-PDGFRA status and response to the therapy: analysis from prospective clinical trial with Imatinib Mesylate.

Abstract

Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells

Articolo

Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway.

Abstract

Thalidomide in the treatment of patients with myelodysplastic syndromes or smouldering acute myeloid leukemia.

Abstract

The achievement of molecular complete remission during treatment with Imatinib mesylate correlates with relapse free survival in bcr/abl-positive acute lymphoid leukemia patients.

Articolo

The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis.

Articolo

The effect of allogeneic stem cell transplantation on outcome in cytogenetically normal acute myeloid leukemia patients and correlation with Pgp expression.

Abstract

The histone deacetylase inhibitor ITF2357 (Givinostat) promotes Burkitt’s lymphoma cell line death modulating micro-RNA and Tissue Transglutaminase 2 expression

Abstract

Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation.

Articolo

Treatment of early stage B-cell chronic lymphocytic leukemia with alpha-interferon

Articolo

Treatment of patients with chronic myeloid leukemia (CML) resistant to imatinib

Articolo

Two more inv(16) acute myeloid leukemia cases with infrequent CBFalpha-MYH11 fusion transcript: clinical and molecular findings.

Articolo

Update of cytogenetic and molecular response in 88 elderly PH+ chronic myeloid leukemia patients enrolled in the phase II explorative study of intermittent imatinib (IM) treatment (INTERIM).

Abstract

Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib

Articolo

Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions.

Articolo

WT-1 FROM PERIPHERAL BLOOD PREDICTS RELAPSE IN AML PATIENTS UNDERGOING STEM CELL TRANSPLANTATION

Abstract

[Chronic myeloid leukemia: progress and prospects]

Articolo

[Multidrug resistance in acute nonlymphoid leukemia]

Articolo

[Update on the prognosis of chronic myeloid leukemia]

Articolo

“Lock-therapy antifungina”

Articolo

No Results Found

HAEMATOLOGICA

Dati Generali

Pubblicazioni (232)